Literature DB >> 3676932

Re-evaluating the cost of outpatient cancer chemotherapy.

H B Wodinsky1, C DeAngelis, J J Rusthoven, I G Kerr, D Sutherland, N Iscoe, R Buckman, M Kornijenko.   

Abstract

Chemotherapy for common malignant tumours has historically been considered relatively expensive. An examination of costs at the Toronto-Bayview Regional Cancer Centre and Sunnybrook Medical Centre, Toronto, suggests that this perception is not accurate. The cost of chemotherapeutic agents administered on an outpatient basis over 4 to 6 months in established drug protocols ranged from $260 to $5374 (mean $2224). The total cost of outpatient administration was estimated to be $152.53 per dose, compared with $185.39 for inpatient administration of the same protocol, a difference of 22%. The difference was predominantly due to a higher allocated per-diem charge at the medical centre. The results indicate that outpatient administration reduces the overall cost of chemotherapy.

Entities:  

Mesh:

Year:  1987        PMID: 3676932      PMCID: PMC1267378     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  5 in total

1.  Cost of outpatient chemotherapy.

Authors:  K C Calman; J G McVie; M Soukop; M Richardson; J Donald
Journal:  Br Med J       Date:  1978-02-25

2.  Cost of health care services in the treatment of cancer.

Authors:  P L Ilbery
Journal:  Aust Fam Physician       Date:  1978-08

3.  Cancer chemotherapy in advanced malignant disease. A cost benefit analysis.

Authors:  W Mattsson; I Gynning; B Carlsson; S E Mauritzon
Journal:  Acta Radiol Oncol Radiat Phys Biol       Date:  1979

4.  Nonmedical costs to patients and their families associated with outpatient chemotherapy.

Authors:  P S Houts; A Lipton; H A Harvey; B Martin; M A Simmonds; R H Dixon; S Longo; T Andrews; R A Gordon; J Meloy
Journal:  Cancer       Date:  1984-06-01       Impact factor: 6.860

5.  Counting the costs of cancer therapy.

Authors:  M L Friedlander; M H Tattersall
Journal:  Eur J Cancer Clin Oncol       Date:  1982-12
  5 in total
  4 in total

1.  High technology drugs for cancer: the decision process for adding to a formulary.

Authors:  J L Glennie; D M Woloschuk; K W Hall
Journal:  Pharmacoeconomics       Date:  1993-12       Impact factor: 4.981

2.  Fair and effective resource allocation in cancer care: uncharted territory?

Authors:  J A Green; C Williams; A Cribb; B Brecher; M Evans
Journal:  Health Care Anal       Date:  1996-02

3.  Lung cancer in the 1990s.

Authors:  N Murray
Journal:  Can Fam Physician       Date:  1990-05       Impact factor: 3.275

Review 4.  Costs and benefits of outpatient therapy.

Authors:  E B Rubenstein
Journal:  Support Care Cancer       Date:  1994-09       Impact factor: 3.603

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.